294 related articles for article (PubMed ID: 31904558)
21. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
Mahoney KM; Freeman GJ; McDermott DF
Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
[TBL] [Abstract][Full Text] [Related]
22. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination.
Chen MC; Huang SF; Lai KY; Ling MH
Biomaterials; 2013 Apr; 34(12):3077-86. PubMed ID: 23369214
[TBL] [Abstract][Full Text] [Related]
23. Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3.
Hayakawa T; Yaguchi T; Kawakami Y
Cancer Sci; 2020 Dec; 111(12):4326-4335. PubMed ID: 33006786
[TBL] [Abstract][Full Text] [Related]
24. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
[TBL] [Abstract][Full Text] [Related]
25. Transcutaneous tumor vaccination combined with anti-programmed death-1 monoclonal antibody treatment produces a synergistic antitumor effect.
Song X; Jiang Y; Zhang W; Elfawal G; Wang K; Jiang D; Hong H; Wu J; He C; Mo X; Wang H
Acta Biomater; 2022 Mar; 140():247-260. PubMed ID: 34843953
[TBL] [Abstract][Full Text] [Related]
26. A universal powder-laden crosslinked chitosan microneedle patch for high-dose controllable drug delivery.
He Y; Zang M; Zhang J; Cheng H; Cui Y; Wang D; Zhang H; Guan X; Wang S; Yuan Y; Gao Y
Int J Biol Macromol; 2024 Jan; 255():127988. PubMed ID: 37956809
[TBL] [Abstract][Full Text] [Related]
27. Intracorneal injection of a detachable hybrid microneedle for sustained drug delivery.
Lee K; Song HB; Cho W; Kim JH; Kim JH; Ryu W
Acta Biomater; 2018 Oct; 80():48-57. PubMed ID: 30267886
[TBL] [Abstract][Full Text] [Related]
28. Transdermal Delivery of Luteinizing Hormone-releasing Hormone with Chitosan Microneedles: A Promising Tool for Androgen Deprivation Therapy.
Chen MY; Chen YY; Tsai HT; Tzai TS; Chen MC; Tsai YS
Anticancer Res; 2017 Dec; 37(12):6791-6797. PubMed ID: 29187457
[TBL] [Abstract][Full Text] [Related]
29. Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma.
Zhang N; Song J; Liu Y; Liu M; Zhang L; Sheng D; Deng L; Yi H; Wu M; Zheng Y; Wang Z; Yang Z
J Control Release; 2019 Jul; 306():15-28. PubMed ID: 31132380
[TBL] [Abstract][Full Text] [Related]
30. Cost-effective Fabrication of Chitosan Microneedles for Transdermal Drug Delivery.
Sadeqi A; Nejad HR; Kiaee G; Sonkusale S
Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():5737-5740. PubMed ID: 30441639
[TBL] [Abstract][Full Text] [Related]
31. Microneedles: A smart approach and increasing potential for transdermal drug delivery system.
Waghule T; Singhvi G; Dubey SK; Pandey MM; Gupta G; Singh M; Dua K
Biomed Pharmacother; 2019 Jan; 109():1249-1258. PubMed ID: 30551375
[TBL] [Abstract][Full Text] [Related]
32. Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors.
Gentzler R; Hall R; Kunk PR; Gaughan E; Dillon P; Slingluff CL; Rahma OE
Immunotherapy; 2016 May; 8(5):583-600. PubMed ID: 27140411
[TBL] [Abstract][Full Text] [Related]
33. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
Shah V; Choudhury BK
AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
[TBL] [Abstract][Full Text] [Related]
34. Construction of microneedle-assisted co-delivery platform and its combining photodynamic/immunotherapy.
Chen SX; Ma M; Xue F; Shen S; Chen Q; Kuang Y; Liang K; Wang X; Chen H
J Control Release; 2020 Aug; 324():218-227. PubMed ID: 32387551
[TBL] [Abstract][Full Text] [Related]
35. Dissolvable layered microneedles with core-shell structures for transdermal drug delivery.
Wang QL; Zhang XP; Chen BZ; Guo XD
Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():143-147. PubMed ID: 29208271
[TBL] [Abstract][Full Text] [Related]
36. Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats.
Ling MH; Chen MC
Acta Biomater; 2013 Nov; 9(11):8952-61. PubMed ID: 23816646
[TBL] [Abstract][Full Text] [Related]
37. Efficient drug delivery to lymph nodes by intradermal administration and enhancement of anti-tumor effects of immune checkpoint inhibitors.
Tanaka R; Hiramitsu M; Shimizu S; Kawashima S; Sato A; Iwase Y
Cancer Treat Res Commun; 2023; 36():100740. PubMed ID: 37437382
[TBL] [Abstract][Full Text] [Related]
38. Multifunctional Microneedle Patches via Direct Ink Drawing of Nanocomposite Inks for Personalized Transdermal Drug Delivery.
Li Y; Chen K; Pang Y; Zhang J; Wu M; Xu Y; Cao S; Zhang X; Wang S; Sun Y; Ning X; Wang X; Kong D
ACS Nano; 2023 Oct; 17(20):19925-19937. PubMed ID: 37805947
[TBL] [Abstract][Full Text] [Related]
39. Progress and perspective of microneedle system for anti-cancer drug delivery.
Li D; Hu D; Xu H; Patra HK; Liu X; Zhou Z; Tang J; Slater N; Shen Y
Biomaterials; 2021 Jan; 264():120410. PubMed ID: 32979655
[TBL] [Abstract][Full Text] [Related]
40. Harnessing the bioresponsive adhesion of immuno-bioglue for enhanced local immune checkpoint blockade therapy.
Joo KI; Jeong Y; Hwang SM; Shin M; Lee J; Sharma G; Lee H; Im SH; Cha HJ
Biomaterials; 2020 Dec; 263():120380. PubMed ID: 32942128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
